Cryosite director, Andrew Kroger, has this month outlaid more than $500,000 on hoovering CTE shares. He's built his stake to 43.25%.
What's he up to? Is he heading for 50%? A buy out? Or a sell out?
Whatever, Kroger's conviction on CTE's investment merits would be comforting to shareholders, including #2 ranker DMX Asset Managment.
DMX director Steven McCarthy engineered a CTE buying operation in the first two weeks 0f March.
The Sydney-based insto has doubled its money.
- Forums
- ASX - By Stock
- CTE
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-2
Featured News
Add CTE (ASX) to my watchlist
(20min delay)
|
|||||
Last
85.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.48M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 551 | 82.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 3399 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 551 | 0.820 |
2 | 1270 | 0.810 |
2 | 13238 | 0.795 |
1 | 2094 | 0.785 |
1 | 1026 | 0.750 |
Price($) | Vol. | No. |
---|---|---|
0.850 | 3399 | 1 |
0.880 | 9015 | 1 |
0.890 | 29745 | 1 |
1.000 | 50 | 1 |
0.000 | 0 | 0 |
Last trade - 07.00am 07/05/2024 (20 minute delay) ? |
Featured News
CTE (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online